Northern Trust Corp Clearside Biomedical, Inc. Transaction History

Northern Trust Corp

$709 Billion
Q2 2025

A detailed history of Northern Trust Corp transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 165,499 shares of CLSD stock, worth $71,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,499

Previous 165,499 -0.0%

Holding current value

$71,164

Previous $152,000 13.16%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.87 - $1.58 $27,881 - $50,635	32,048 Added 24.01%	165,499 $165,000
Q2 2024 Aug 14, 2024	SELL	$1.08 - $1.58 $90 - $132	-84 Reduced 0.06%	133,451 $173,000
Q1 2024 May 14, 2024	BUY	$1.2 - $2.02 $50,109 - $84,351	41,758 Added 45.5%	133,535 $204,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $1.18 $2,044 - $3,547	-3,006 Reduced 3.17%	91,777 $107,000
Q3 2023 Nov 13, 2023	SELL	$0.82 - $1.27 $977 - $1,513	-1,192 Reduced 1.24%	94,783 $82,000
Q2 2023 Aug 11, 2023	SELL	$0.97 - $1.48 $384 - $586	-396 Reduced 0.41%	95,975 $107,000
Q1 2023 May 15, 2023	BUY	$0.93 - $1.66 $6,891 - $12,300	7,410 Added 8.33%	96,371 $100,000
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.49 $10,198 - $19,534	-7,845 Reduced 8.1%	88,961 $131,000
Q1 2022 May 13, 2022	BUY	$1.35 - $2.88 $27 - $57	20 Added 0.02%	96,806 $222,000
Q4 2021 Feb 08, 2022	SELL	$2.72 - $5.72 $17,508 - $36,819	-6,437 Reduced 6.24%	96,786 $266,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $74,464 - $111,002	15,417 Added 17.56%	103,223 $619,000
Q1 2021 May 12, 2021	BUY	$2.24 - $4.25 $9,999 - $18,972	4,464 Added 5.36%	87,806 $217,000
Q4 2020 Feb 11, 2021	BUY	$1.32 - $2.74 $1,980 - $4,110	1,500 Added 1.83%	83,342 $228,000
Q3 2020 Nov 16, 2020	SELL	$1.45 - $2.0 $11,552 - $15,934	-7,967 Reduced 8.87%	81,842 $126,000
Q2 2020 Aug 14, 2020	BUY	$1.55 - $2.41 $1,505 - $2,340	971 Added 1.09%	89,809 $169,000
Q1 2020 May 14, 2020	BUY	$1.32 - $3.77 $26,282 - $75,064	19,911 Added 28.89%	88,838 $151,000
Q4 2019 Feb 14, 2020	BUY	$0.62 - $3.4 $4,296 - $23,562	6,930 Added 11.18%	68,927 $200,000
Q3 2019 Nov 13, 2019	SELL	$0.59 - $1.32 $137,703 - $308,081	-233,395 Reduced 79.01%	61,997 $39,000
Q2 2019 Aug 13, 2019	SELL	$0.97 - $1.42 $18,419 - $26,964	-18,989 Reduced 6.04%	295,392 $287,000
Q1 2019 May 13, 2019	SELL	$1.1 - $1.74 $1,316 - $2,082	-1,197 Reduced 0.38%	314,381 $434,000
Q4 2018 Feb 12, 2019	SELL	$1.0 - $6.12 $859 - $5,257	-859 Reduced 0.27%	315,578 $337,000
Q3 2018 Nov 14, 2018	BUY	$6.03 - $11.24 $28,232 - $52,625	4,682 Added 1.5%	316,437 $1.95 Million
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $609,060 - $993,910	68,357 Added 28.08%	311,755 $3.33 Million
Q1 2018 May 09, 2018	BUY	$5.57 - $14.28 $108,481 - $278,117	19,476 Added 8.7%	243,398 $2.61 Million
Q4 2017 Feb 14, 2018	SELL	$5.78 - $9.12 $13,137 - $20,729	-2,273 Reduced 1.0%	223,922 $1.57 Million
Q3 2017 Nov 13, 2017	BUY	$6.73 - $8.74 $1.52 Million - $1.98 Million	226,195	226,195 $1.98 Million

Others Institutions Holding CLSD

# of Institutions

Shares Held

11.8M

Call Options Held

Put Options Held

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $25.9M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Clearside Biomedical, Inc. Transaction History